MKM Subarkhan, L Ren, B Xie, C Chen, Y Wang… - European journal of …, 2019 - Elsevier
Ruthenium complexes have attracted a surge of interest as anticancer drug candidates
because of their low toxicity, diversity in mode-of-actions and non-cross drug resistance with …